Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
Isabelle M DudleyCeren SungucEmma J HeymerDavid L WinterJop C TeepenFabiën Naomi BelleEdit BárdiFrancesca BagnascoThorgerdur GudmundsdottirRoderick SkinnerGisela MichelJulianne ByrneHilde ØfstaasMomcilo JankovicMaja Česen MazićLuzius MaderJacqueline J LoonenStanislaw GarwiczThomas WiebeDaniela AlessiRodrigue Setcheou AllodjiNadia HaddyDesiree GrabowPeter KaatschMelanie KaiserMilena Maria MauleZsuzsanna JakabMaria Winther GunnesMonica TerenzianiLorna Zadravec ZaletelClaudia Elisabeth KuehniRiccardo HauptFlorent de VathaireLeontien C M KremerPäivi Maria LähteenmäkiJeanette Falck WintherLars HjorthMichael M HawkinsRaoul C ReulenPublished in: Cancer (2022)
In addition to HL, the authors show here for the first time that survivors of Wilms tumor, leukemia, and bone sarcoma are at risk of NHL. Survivors and health care professionals should be aware of the risk of NHL in these survivors and in any survivors treated with chemotherapy.